A VLCKD reduces glucose and insulin levels, improving insulin sensitivity and leading to an improvement in glycaemic control for patients with type 2 diabetes mellitus and an improvement in gonadal function in women (PCOS) [87,88,89,90]. The gene discussed is INS; the disease is type 2 diabetes mellitus.